Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions

Reuters

Thu, December 18, 2025 astatine 8:33 AM CST 1 min read

Dec 18 (Reuters) - Shares of cannabis firms roseate successful premarket trading connected Thursday, driven by ​expectations that U.S. President Donald Trump volition ‌sign an enforcement bid easing national regulations connected marijuana.

Central to ‌the statement implicit marijuana regularisation are calls to reclassify cannabis arsenic a little unsafe drug, a determination that would correspond the astir important alteration successful marijuana ⁠policy since 1970.

Such ‌a reclassification volition not legalize cannabis but could little taxation burdens for firms, accelerate ‍research, alteration standardized cause improvement and amended entree to capital.

U.S.-listed shares of Tilray gained astir 5%, SNDL roseate ​3%, Canopy Growth much than 5% and AdvisorShares ‌Pure US Cannabis ETF was up 6.5% earlier the bell.

A reclassification would determination marijuana from Schedule I, which includes substances similar heroin, ecstasy and peyote that person nary accepted aesculapian use, to Schedule III, ⁠which covers substances with a ​moderate to debased hazard of ​physical oregon intelligence dependence.

Trump is considering a Medicare aviator programme that would supply immoderate ‍seniors entree ⁠to CBD, according to reports.

Rescheduling and Medicare sum would apt pull investments from fiscal institutions and ⁠other investors.

(Reporting by Puyaan Singh, Christy Santosh, further reporting ‌by Sriparna Roy successful Bengaluru; Editing by Sriraj ‌Kalluvila and Saumyadeb Chakrabarty)